Tobin G, Asztély A, Edwards A V, Ekström J, Håkanson R, Sundler F
Department of Physiology and Pharmacology, Göteborg University, Sweden.
Neuroscience. 1995 May;66(1):227-35. doi: 10.1016/0306-4522(94)00622-c.
Pituitary adenylate cyclase activating peptide (PACAP), a recently described vasoactive intestinal peptide-like neuropeptide, was found to be present in neurons in the submandibular gland of the ferret, where PACAP-immunoreactive nerve fibers were distributed around blood vessels, acini and ducts. Most of the PACAP-immunoreactive fibres were distinct from those storing vasoactive intestinal peptide. PACAP occurs in tissues as PACAP1-38 and PACAP1-27. PACAP1-38 and PACAP1-27 but not PACAP16-38 displayed biological activity with about the same potency. They exerted vasodilator effects on the submandibular vasculature, which resulted in a greater fall in vascular resistance than an equimolar dose of vasoactive intestinal peptide. The vasodilator response was independent of muscarinic receptor activation. Neither vasoactive intestinal peptide nor PACAP alone evoked any flow of saliva. However, both vasoactive intestinal peptide and PACAP enhanced the fluid response to acetylcholine, and the flow of saliva as well as the output of protein in response to parasympathetic nerve stimulation, vasoactive intestinal peptide being more potent than PACAP. In vitro, protein was released from submandibular gland tissue in response to both vasoactive intestinal peptide and PACAP, vasoactive intestinal peptide being more potent than PACAP. PACAP (and vasoactive intestinal peptide) exerted its in vitro effect following adrenoceptor and muscarinic blockade and following degeneration of sympathetic nerves. Sympathetic denervation combined with parasympathetic preganglionic denervation resulted in supersensitivity to both vasoactive intestinal peptide and PACAP. The fact that PACAP and vasoactive intestinal peptide occur in different nerve fibre populations suggests different roles for the two peptides in the submandibular gland.(ABSTRACT TRUNCATED AT 250 WORDS)
垂体腺苷酸环化酶激活肽(PACAP)是一种最近被描述的血管活性肠肽样神经肽,发现其存在于雪貂下颌下腺的神经元中,PACAP免疫反应性神经纤维分布在血管、腺泡和导管周围。大多数PACAP免疫反应性纤维与储存血管活性肠肽的纤维不同。PACAP以PACAP1 - 38和PACAP1 - 27的形式存在于组织中。PACAP1 - 38和PACAP1 - 27具有生物活性,而PACAP16 - 38则没有,它们的效力大致相同。它们对下颌下血管系统具有血管舒张作用,导致血管阻力下降幅度大于等摩尔剂量的血管活性肠肽。血管舒张反应与毒蕈碱受体激活无关。单独的血管活性肠肽和PACAP都不会引起任何唾液分泌。然而,血管活性肠肽和PACAP都增强了对乙酰胆碱的液体反应,以及对副交感神经刺激的唾液分泌和蛋白质分泌,血管活性肠肽比PACAP更有效。在体外,血管活性肠肽和PACAP都能使下颌下腺组织释放蛋白质,血管活性肠肽比PACAP更有效。PACAP(和血管活性肠肽)在肾上腺素能受体和毒蕈碱受体被阻断以及交感神经变性后发挥其体外作用。交感神经去神经支配与副交感神经节前纤维去神经支配相结合导致对血管活性肠肽和PACAP的超敏反应。PACAP和血管活性肠肽存在于不同神经纤维群体这一事实表明这两种肽在下颌下腺中具有不同的作用。(摘要截取自250字)